Vaccines - Pakistan

Pakistan

Pakistan's Vaccines market is expected to witness significant growth in the coming years.
According to projections, the market's revenue is projected to reach US$610.00m by 2024.
This growth is anticipated to continue with an annual growth rate of -13.72% from 2024 to 2029.
By the end of 2029, the market volume is estimated to reach US$291.70m.
In terms of global comparison, it is worth noting that United States is expected to generate the highest revenue in the Vaccines market, with a projected revenue of US$29,120.00m by 2024.
Pakistan's vaccine market has seen a significant rise in demand due to the government's efforts in promoting immunization programs.

Key regions: Australia, Italy, France, South Korea, Brazil

Market

Region

Region comparison

Currency

Analyst Opinion

The demand for vaccines in Pakistan has been steadily increasing in recent years, driven by various factors such as a growing population, increasing awareness about the importance of vaccination, and the government's efforts to improve healthcare access in the country.

Customer preferences: Pakistan has a large population of over 220 million people, with a significant portion living in rural areas with limited access to healthcare facilities. Despite this, there has been a growing awareness among the population about the importance of vaccination in preventing the spread of infectious diseases. As a result, there has been an increasing demand for vaccines in the country, particularly for diseases such as polio, hepatitis, and measles.

Trends in the market: The vaccines market in Pakistan has been growing steadily in recent years, with a focus on improving healthcare access and increasing vaccination coverage across the country. The government has been actively involved in promoting vaccination programs, particularly for children, and has been working to improve the distribution and availability of vaccines in both urban and rural areas. Additionally, there has been a rise in private healthcare providers offering vaccination services, further driving the growth of the market.

Local special circumstances: Pakistan has faced several challenges in its efforts to improve vaccination coverage, particularly in more remote areas of the country. These include a lack of infrastructure and resources, as well as concerns around vaccine hesitancy and misinformation. The country has also been dealing with outbreaks of diseases such as polio, which has led to a renewed focus on vaccination efforts and greater investment in healthcare infrastructure.

Underlying macroeconomic factors: Pakistan's healthcare sector has been growing in recent years, driven by increasing government investment and a rising demand for healthcare services. However, the country still faces significant challenges in terms of healthcare access and affordability, particularly in more rural areas. This has led to a growing focus on public-private partnerships and greater investment in healthcare infrastructure to improve access and affordability for the population. Overall, the vaccines market in Pakistan is expected to continue growing in the coming years, driven by increasing demand for healthcare services and a growing focus on improving healthcare access and infrastructure across the country.

Methodology

Data coverage:

Data encompasses B2B, B2G, and B2C spend. Figures are based on drug revenues allocated to the country where the money is spent. Monetary values are given at manufacturer price level excluding VAT.

Modeling approach / Market size:

Market sizes are determined by a top-down approach, based on a specific rationale for each market. As a basis for evaluating markets, we use financial information of the key players by market. Next, we use relevant key market indicators and data from country-specific associations, such as industry associations. This data helps us estimate the market size for each country individually.

Forecasts:

In our forecasts, we apply diverse forecasting techniques. The selection of forecasting techniques is based on the behavior of the particular market. For example, forecasts are based on historical developments, current trends, and key market indicators, using advanced statistical methods. The main driver is healthcare expenditure. Expiring patents and new drugs in the pipeline are also considered.

Additional notes:

Data is modeled in US$ using current exchange rates. The market is updated twice per year in case market dynamics change. The impact of the COVID-19 pandemic is considered at a country-specific level. This market comprises prescription drugs and all OTC drugs covered in the Statista OTC Pharmaceuticals market. However, in the OTC Pharmaceuticals market, revenues are based on end-consumer prices.